NCT04412096View on ClinicalTrials.gov

Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance

PHASE4CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

November 23, 2020

Primary Completion Date

May 22, 2025

Study Completion Date

May 22, 2025

Conditions
GlaucomaOHT - Ocular Hypertension
Interventions
DRUG

Timolol 0.5% ophthalmic solution

1 drop BID

DRUG

Latanoprost 0.005% Ophthalmic Solution

1 drop QD

Trial Locations (3)

43212

The Ohio State University, Columbus

55905

Mayo Clinic, Rochester

68105

University of Nebraska Medical Center, Omaha

Sponsors

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

University of Nebraska

OTHER

collaborator

National Eye Institute (NEI)

NIH

collaborator

Mayo Clinic

OTHER

lead

Ohio State University

OTHER